(19)
(11) EP 0 776 367 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.12.2003 Bulletin 2003/49

(45) Mention of the grant of the patent:
23.07.2003 Bulletin 2003/30

(21) Application number: 95928791.3

(22) Date of filing: 09.08.1995
(51) International Patent Classification (IPC)7: C12N 15/16
(86) International application number:
PCT/US9510/075
(87) International publication number:
WO 9600/5310 (22.02.1996 Gazette 1996/09)

(54)

DNA ENCODING TURKEY HYPOTHALAMIC VASOACTIVE INTESTINAL PEPTIDE

TRUTHAHN HYPOTHALAMISCHES GEFÄSSAKTIVES DARMPEPTID KODIERENDE DNS

ADN CODANT UN PEPTIDE INTESTINAL VASOACTIF HYPOTHALAMIQUE DE DINDE

(84) Designated Contracting States:
DE FR GB IT

(30) Priority: 09.08.1994 US 287668
09.05.1995 US 437612

(43) Date of publication of application:
04.06.1997 Bulletin 1997/23

(73) Proprietor: REGENTS OF THE UNIVERSITY OF MINNESOTA
Minneapolis, Minnesota 55455 (US)

(72) Inventor:
  • EL HALAWANI, Mohamed E.
    Shoreview, MN 55126 (US)

(74) Representative: Maiwald, Walter, Dr. Dipl.-Chem. et al
Maiwald Patentanwalts GmbH Postfach 33 05 23
80065 München
80065 München (DE)


(56) References cited: : 
WO-A-94/08616
 US-A- 4 016 258
   
  • DATABASE STRAND AN : emvrt : gg09350, 31 May 1994 & UNPUBLISHED, FARLIN ET AL. 'Structure of chicken vasoactive intestinal peptide cDNA'
  • ENDOCRINOLOGY, vol. 136, no. 6, June 1995 pages 2602-2610, YOU ET AL. 'Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion'
  • GEN. COMP. ENDOCRINOL., vol. 87, no. 3, September 1992 pages 481-493, MAURO ET AL. 'Effects of reproductive status, ovariectomy and photoperiod on Vasoactive intestinal peptide in the female turkey'
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).